retatrutide clinical trial results 2024 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide Severe Obesity Trial Shows

Storage Protocols: Lyophilized (Powder): Store in a freezer at -20C for long-term stability (up to 24 months)

This applies across the glucose support supplement category - oral and transdermal formats alike

We were quite surprised by the strength of the association between GLP-1 medication use and the lower risk of developing macular degeneration, says Benjamin Young, MD, a corresponding author and an assistant professor of ophthalmology at OHSU Health in Portland, Oregon

Studies have shown that GLP-1 agonists can trigger effects in the brain, the heart, the liver, the pancreas, the stomach, and the musclesmeaning that they could have implications for conditions other than type 2 diabetes and obesity, such as heart disease, kidney disease, liver disease, and even neurological conditions such as Alzheimer's disease